Display options
Cite
Borbély A, Figueras E, Martins A, et al. Conjugates of Cryptophycin and RGD or . ChemistryOpen. 2019;8(6):737-742doi: 10.1002/open.201900110.
Borbély, A., Figueras, E., Martins, A., Bodero, L., Raposo Moreira Dias, A., López Rivas, P., Pina, A., Arosio, D., Gallinari, P., Frese, M., Steinkühler, C., Gennari, C., Piarulli, U., & Sewald, N. (2019). Conjugates of Cryptophycin and RGD or . ChemistryOpen, 8(6), 737-742. https://doi.org/10.1002/open.201900110
Borbély, Adina, et al. "Conjugates of Cryptophycin and RGD or ." ChemistryOpen vol. 8,6 (2019): 737-742. doi: https://doi.org/10.1002/open.201900110
Borbély A, Figueras E, Martins A, Bodero L, Raposo Moreira Dias A, López Rivas P, Pina A, Arosio D, Gallinari P, Frese M, Steinkühler C, Gennari C, Piarulli U, Sewald N. Conjugates of Cryptophycin and RGD or . ChemistryOpen. 2019 Jun 07;8(6):737-742. doi: 10.1002/open.201900110. eCollection 2019 Jun. PMID: 31275795; PMCID: PMC6587324.
Copy Download .nbib Format: NLM
Share it on

ChemistryOpen. 2019 Jun 07;8(6):737-742. doi: 10.1002/open.201900110. eCollection 2019 Jun.

Conjugates of Cryptophycin and RGD or .

ChemistryOpen

Adina Borbély, Eduard Figueras, Ana Martins, Lizeth Bodero, André Raposo Moreira Dias, Paula López Rivas, Arianna Pina, Daniela Arosio, Paola Gallinari, Marcel Frese, Christian Steinkühler, Cesare Gennari, Umberto Piarulli, Norbert Sewald

Affiliations

  1. Organic and Bioorganic Chemistry, Department of Chemistry Bielefeld University Universitätsstraße 25 DE-33615 Bielefeld Germany.
  2. Exiris s.r.l. Via di Castel Romano 100 IT-00128 Rome Italy.
  3. Dipartimento di Scienza e Alta Tecnologia Università degli Studi dell'Insubria Via Valleggio, 11 IT-22100 Como Italy.
  4. Dipartimento di Chimica Università degli Studi di Milano Via C. Golgi, 19 IT-20133 Milano Italy.
  5. Istituto di Scienze e Tecnologie Molecolari (ISTM) CNR Via C. Golgi, 19 IT-20133 Milano Italy.

PMID: 31275795 PMCID: PMC6587324 DOI: 10.1002/open.201900110

Abstract

RGD-cryptophycin and

Keywords: antitumor agents; cancer; drug delivery; integrins; peptidomimetics

Conflict of interest statement

A.M. is an employee of Exiris, P.G. is a shareholder of Exiris. C.S. is a shareholder of Exiris.

References

  1. Beilstein J Org Chem. 2018 Feb 14;14:407-415 - PubMed
  2. Chemistry. 2009 Nov 16;15(45):12184-8 - PubMed
  3. Angew Chem Int Ed Engl. 2014 Apr 7;53(15):3796-827 - PubMed
  4. Adv Ther. 2017 May;34(5):1015-1035 - PubMed
  5. Lung Cancer. 2003 Feb;39(2):197-9 - PubMed
  6. Pharm Res. 2015 Nov;32(11):3526-40 - PubMed
  7. Future Med Chem. 2017 Apr;9(6):579-604 - PubMed
  8. Invest New Drugs. 2005 Jun;23(3):213-24 - PubMed
  9. Curr Med Chem. 2010;17(13):1255-99 - PubMed
  10. Mol Pharm. 2018 Sep 4;15(9):3603-3616 - PubMed
  11. Chemistry. 2017 Oct 17;23(58):14410-14415 - PubMed
  12. Int J Gynecol Cancer. 2006 Jan-Feb;16(1):71-6 - PubMed
  13. Biochem Biophys Res Commun. 2016 Sep 23;478(3):1280-5 - PubMed
  14. J Clin Invest. 1992 Jun;89(6):2018-22 - PubMed
  15. Int J Cancer. 1998 Sep 11;77(6):869-73 - PubMed
  16. Chemistry. 2015 Apr 27;21(18):6921-9 - PubMed
  17. J Med Chem. 2013 Mar 14;56(5):1853-64 - PubMed
  18. Mol Pharm. 2012 Nov 5;9(11):2961-73 - PubMed
  19. Br J Cancer. 2004 Feb 9;90(3):561-5 - PubMed
  20. J Pept Sci. 2017 Jul;23(7-8):514-531 - PubMed
  21. Chemistry. 2013 Mar 11;19(11):3563-7 - PubMed
  22. Nat Rev Drug Discov. 2015 Mar;14(3):203-19 - PubMed
  23. Bioorg Med Chem Lett. 2015 Feb 15;25(4):864-8 - PubMed
  24. ChemistryOpen. 2019 Jun 07;8(6):737-742 - PubMed
  25. Nat Rev Drug Discov. 2017 May;16(5):315-337 - PubMed
  26. Beilstein J Org Chem. 2018 Jun 1;14:1281-1286 - PubMed
  27. J Cell Sci. 2011 Feb 15;124(Pt 4):515-22 - PubMed
  28. Clin Exp Metastasis. 2002;19(5):427-36 - PubMed
  29. J Biol Chem. 2008 Jul 11;283(28):19757-68 - PubMed
  30. Angew Chem Int Ed Engl. 2012 Jul 27;51(31):7702-5 - PubMed
  31. Future Med Chem. 2018 Sep 1;10(18):2201-2226 - PubMed
  32. J Med Chem. 2012 Dec 13;55(23):10460-74 - PubMed
  33. Nat Rev Cancer. 2018 Sep;18(9):533-548 - PubMed
  34. Chemistry. 2017 Jun 12;23(33):7910-7914 - PubMed
  35. Nat Rev Cancer. 2008 Aug;8(8):604-17 - PubMed
  36. Angew Chem Int Ed Engl. 2013 Jan 28;52(5):1384-402 - PubMed
  37. J Biol Chem. 1987 Dec 25;262(36):17703-11 - PubMed
  38. J Med Chem. 2018 Sep 13;61(17):7474-7485 - PubMed
  39. Biol Open. 2012 Apr 15;1(4):329-40 - PubMed
  40. Sci Rep. 2017 Jan 11;7:39805 - PubMed
  41. ACS Omega. 2018 Nov 30;3(11):14726-14731 - PubMed
  42. J Org Chem. 2010 Oct 15;75(20):6953-60 - PubMed
  43. Angew Chem Int Ed Engl. 2018 Mar 19;57(13):3298-3321 - PubMed
  44. Med Res Rev. 2016 May;36(3):494-575 - PubMed
  45. Nat Rev Cancer. 2010 Jan;10(1):9-22 - PubMed
  46. Science. 1987 Oct 23;238(4826):491-7 - PubMed
  47. Curr Top Med Chem. 2016;16(3):314-29 - PubMed
  48. Nat Prod Rep. 2013 Jul;30(7):924-40 - PubMed
  49. Chemistry. 2019 Feb 1;25(7):1696-1700 - PubMed
  50. Lab Invest. 2001 Dec;81(12):1615-26 - PubMed
  51. Angew Chem Int Ed Engl. 2002 Oct 18;41(20):3767-74 - PubMed
  52. Chem Rev. 2017 Oct 11;117(19):12133-12164 - PubMed
  53. ChemistryOpen. 2016 Dec 09;6(1):128-136 - PubMed

Publication Types